Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: A single center study

Leukemia and Lymphoma

Volumn 45, Issue 5, 2004, Pages 971-977

  Mitterbauer, Margit ^a,b   Mitterbauer Hohendanner, Gerlinde ^b   Sperr, Wolfgang R ^b   Kalhs, Peter ^a   Greinix, Hildegard T ^a   Fonatsch, Christa ^c   Haas, Oskar A ^d   Jäger, Ulrich ^b   Mannhalter, Christine ^b   Lechner, Klaus ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

AML; AML1 ETO RT PCR; Long term disease free survival; Molecular remission; t(8; 21)

Indexed keywords

AMSACRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOABLATIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD SAMPLING; BONE MARROW CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LONG TERM CARE; MALE; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PERIPHERAL CIRCULATION; PREDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 11144356481     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001638913     Document Type: Article

References (35)

1. Byrd, J.C., Mrozek, K., Dodge, R.K., Carroll, A.J., Edwards, C.G., Arthur, D.C., et al. (2002) "PRetreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)", Blood, 100(13), 4325-4336.
2. Slovak, M.L., Kopecky, K.J., Cassileth, P.A., Harrington, D.H., Theil, K.S., Mohamed, A., et al. (2000) "KAryotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/ Eastern Cooperative Oncology Group study", Blood, 96(13), 4075-4083.
3. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., et al. (1998) "THe importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties", Blood, 92(7), 2322-2333.
4. Byrd, J.C., Dodge, R.K., Carroll, A., Baer, M.R., Edwards, C., Stamberg, J., et al. (1999) "PAtients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered", J. Clin. Oncol., 17(12), 3767-3775.
5. Burnett, A.K., Goldstone, A.H., Stevens, R.M.F., Hann, I.M., Rees, J.K.H., Gray, R.,G., et al. (1998) "RAndomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial. UK Medial Research Council Adult and Children's Leukaemia Working Parties", Lancet, 351(9104), 700-708.
6. Downing, J.R., Head, D.R., Curcio-Brint, A.M., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., et al. (1993) "AN AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation", Blood, 81(11), 2860-2865.
7. Mitterbauer, M., Kusec, R., Schwarzinger, I., Haas, O.A., Lechner, K. and Jaeger, U. (1998) "COmparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML", Ann. Hematol., 76(3-4), 139-143.
8. Yin, J.A. and Grimwade, D. (2002) "MInimal residual disease evaluation in acute myeloid leukaemia", Lancet, 360(9327), 160-162.
9. Grimwade, D. (2002) "THe significance of minimal residual disease in patients with t(15;17)", Best Pract. Res. Clin. Haematol., 15(1), 137-158.
10. Laczika, K., Mitterbauer, G., Mitterbauer, M., Knobl, P., Schwarzinger, I., Greinix, H.T., et al. (2001) "PRospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions", Leuk. Lymphoma, 42(5), 923-931.
11. Marcucci, G., Caligiuri, M.A. and Bloomfield, C.D. (1997) "DEfining the 'absence' of the CBFbeta/MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: A call for definitions", Blood, 90(12), 5022-5024.
12. Jurlander, J., Caligiuri, M.A., Ruutu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., et al. (1996) "PErsistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia", Blood, 88(6), 2183-2191.
13. Kusec, R., Laczika, K., Knobl, P., Friedl, J., Greinix, H., Kahls, P., et al. (1994) "AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation", Leukemia, 8(5), 735-739.
14. Maruyama, F., Stass, S.A., Estey, E.H., Cork, A., Hirano, M., Ino, T., et al. (1994) "DEtection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia", Leukemia, 8(1), 40-45.
15. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., et al. (1996) "PErsistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia", Blood, 87(11), 4789-4796.
16. Nucifora, G., Larson, R.A. and Rowley, J.D. (1993) "PErsistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission", Blood, 82(3), 712-715.
17. Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., et al. (1995) "DIsappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission", Br. J. Haematol., 91(4), 892-898.
18. Saunders, M.J., Tobal, K. and Yin, J.A. (1994) "DEtection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation", Leuk. Res., 18(12), 891-895.
19. Fujimaki, S., Funato, T., Harigae, H., Imaizumi, M., Suzuki, H., Kaneko, Y., et al. (2000) "A quantitative reverse transcriptase polymerase chain reaction method for the detection of leukaemic cells with t(8;21) in peripheral blood", Eur. J. Haematol., 64(4), 252-258.
20. Kondo, M., Kudo, K., Kimura, H., Inaba, J., Kato, K., Kojima, S., et al. (2000) "REal-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia", Leuk. Res., 24(11), 951-956.
21. Krauter, J., Wattjes, M.P., Nagel, S., Heidenreich, O., Krug, U., Kafert, S., et al. (1999) "REal-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients". Br. J. Haematol., 107(1), 80-85.
22. Marcucci, G., Livak, K.J., Bi, W., Strout, M.P., Bloomfield, C.D. and Caligiuri, M.A. (1998) "DEtection of minimal residual disease in patients with AML1/ETO- associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay", Leukemia, 12(9), 1482-1489.
23. Tobal, K., Newton, J., Macheta, M., Chang, J., Morgenstern, G., Evans, P.A., et al. (2000) "MOlecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse", Blood, 95(3), 815-819.
24. Elmaagacli, A.H., Beelen, D.W., Stockova, J., Trzensky, S., Kroll, M., Schaefer, U.W., et al. (1997) "DEtection of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantation", Blood, 90(8), 3230-3231.
25. Morschhauser, F., Cayuela, J.M., Martini, S., Baruchel, A., Rousselot, P., Socie, G., et al. (2000) "EValuation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients", J. Clin. Oncol., 18(4), 788-794.
26. Sperr, W.R., Piribauer, M., Agis, H., Mitterbauer, M., Geissler, K., Haas, O.A., et al. (2003) "INtermittent intermediate dose ARA-C as consolidation therapy for AML in the elderly", Blood, 90(Suppl. 1), 509a.
27. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., et al. (2001) "HEmatopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus- tumor effects", Blood, 97(11), 3390-3400.
28. Mitelmann, Fe. ISCN (1995) An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger.
29. Mitterbauer, G., Zimmer, C., Fonatsch, C., Haas, O., Thalhammer-Scherrer, R., Schwarzinger, I., et al. (1999) "MOnitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR", Leukemia, 13(10), 1519-1524.
30. Kwok, S. and Higuchi, R. (1989) "AVoiding false positives with PCR", Nature, 339(6221), 237-238.
31. Mannhalter, C., Koizar, D. and Mitterbauer, G. (2000) "EValuation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA", Clin. Chem. Lab. Med., 38(2), 171-177.
32. Asou, H., Tashiro, S., Hamanoto, K., Otsuji, A., Kita, K. and Kamada, M. (1991) "EStablishment of a human acute myeloid leukemia cell line (Kasumi-1) with t(8;21 chromosome translocation", Blood, 77(9), 2031-2036.
33. Costello, R., Sainty, D., Blaise, D., Gastaut, J.A., Gabert, J., Poirel, H., et al. (1997) "PRognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYH11-positive acute myeloblastic leukemia", Blood, 89(6), 2222-2223.
34. Pallisgaard, N., Hokland, P., Riishoj, D.C., Pedersen, B. and Jorgensen, P. (1998) "MUltiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia", Blood, 92(2), 574-588.
35. Miyamoto, T., Weissman, I.L. and Akashi, K. (2000) "AML1/ ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation", Proc. Natl. Acad. Sci. USA, 97(13), 7521-7526.